CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,135,039 | +88.5% | 76,126 | +10.3% | 0.00% | – |
| Q2 2023 | $601,986 | 0.0% | 69,035 | 0.0% | 0.00% | – |
| Q1 2023 | $601,986 | -99.9% | 69,035 | -37.0% | 0.00% | – |
| Q1 2021 | $497,678,000 | +1.5% | 109,621 | +28.3% | 0.00% | – |
| Q4 2020 | $490,369,000 | +202.7% | 85,430 | -22.0% | 0.00% | – |
| Q1 2020 | $162,024,000 | +27.3% | 109,476 | +68.6% | 0.00% | – |
| Q4 2019 | $127,305,000 | -64.8% | 64,951 | -8.0% | 0.00% | – |
| Q3 2019 | $361,595,000 | -24.1% | 70,624 | +6.2% | 0.00% | – |
| Q2 2019 | $476,341,000 | -93.7% | 66,528 | -88.3% | 0.00% | -100.0% |
| Q1 2019 | $7,579,015,000 | +79.8% | 570,709 | +6.6% | 0.01% | +50.0% |
| Q4 2018 | $4,214,275,000 | -35.1% | 535,486 | -8.7% | 0.00% | -20.0% |
| Q3 2018 | $6,495,484,000 | -14.8% | 586,235 | +3.2% | 0.01% | -16.7% |
| Q2 2018 | $7,626,398,000 | -1.0% | 568,286 | -4.2% | 0.01% | 0.0% |
| Q1 2018 | $7,705,876,000 | +42.1% | 593,216 | +0.6% | 0.01% | +20.0% |
| Q4 2017 | $5,423,307,000 | – | 589,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |